CSS LLC’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$123K Buy
+500
New +$127K 0.01% 799
2025
Q4
– Sell
-400
Closed -$182K – 1015
2025
Q3
$182K Buy
+400
New +$163K 0.01% 786
2022
Q4
– Sell
-23,600
Closed -$4.72M – 940
2022
Q3
$4.72M Buy
+23,600
New +$4.5M 0.22% 102

Other funds holding ALNY

CSS LLC's ALNY Position: Q3 2026 in Review

CSS LLC opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 40 shares worth $9.9K. The stake represents ﹤0.01% of the portfolio and ranks #963 among its holdings. This is a return to the name: CSS LLC previously reported a position in ALNY as recently as Q3 2025.

CSS LLC first reported a position in ALNY in Q3 2022 and has held it in 5 quarters since. The position peaked at $2.06M in Q3 2024. 722 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • CSS LLC held 40 shares of Alnylam Pharmaceuticals worth $9.9K as of Q3 2026.
  • Alnylam Pharmaceuticals was a new CSS LLC position in Q3 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of CSS LLC's portfolio in Q3 2026, its #963 holding.
  • CSS LLC first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • CSS LLC's Alnylam Pharmaceuticals position peaked at $2.06M in Q3 2024.
  • 722 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on CSS LLC's 13F filing for Q3 2026, filed 16 Nov 2026.